China's Haisco jumps most in 8 months on Nuvectis licensing deal

Nuvectis Pharma

23/06/2026 03:22

** Shares of Haisco Pharmaceutical Group 002653.SZ jump  9.7% to 54 yuan, on track for their biggest one-day pct rise since October 31, 2025
** Stock hits the highest since June 1 in the third straight session of gains 
** Nuvectis Pharma NVCT.O said on Monday it had licensed exclusive rights outside China to two experimental drugs from Haisco Pharmaceutical Group 002653.SZ, targeting complement-mediated diseases and cancer to broaden its pipeline
** Haisco will receive upfront and near-term payments totaling up to $40 million and is eligible to receive up to $1.42 billion in additional milestone payments, and tiered royalties on future net sales
** YTD, stock up 3.6%, benchmark CSI300 Index .CSI300 up 8.1%



 (Reporting by Donny Kwok)
 ((donny.kwok@thomsonreuters.com))